The CK18 fragments in the blood can indicate NASH and the severity of NAFLD in patients with uncontrolled hepatocyte apoptosis, necrosis, and caspase cleavage. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.